Cardinal Health Completes Acquisition of Syncor And Becomes Leading Provider of Nuclear Pharmacy Services

Jan 02, 2003, 00:00 ET from Cardinal Health, Inc

    DUBLIN, Ohio, Jan. 2 /PRNewswire-FirstCall/ -- Cardinal Health, Inc.
 (NYSE:   CAH) today announced the successful completion of its acquisition of
 Syncor International Corporation.  Cardinal Health is now the leading provider
 of highly profitable nuclear pharmacy services in the United States.  The
 acquisition furthers the company's strategy of broadening its unique products
 and services offering to help improve quality and efficiency in health care.
     Syncor's domestic operations will be integrated with Central Pharmacy
 Services (CPSI) to become the Nuclear Pharmacy Services business of Cardinal
 Health.  Nuclear Pharmacy Services compounds and dispenses
 radiopharmaceuticals for diagnostic and therapeutic use by nuclear medicine
 departments in hospitals and outpatient clinics.  Nuclear Pharmacy Services
 distributes these time-critical pharmaceuticals to approximately 8,000
 customers through an integrated network of more than 170 domestic nuclear
 pharmacies.  Cardinal Health will continue Syncor's previously announced plans
 to sell Syncor's imaging business and further rationalize Syncor's
 international operations.
     "In response to the needs of customers, Cardinal Health has added the
 leading nuclear pharmacy services capability to its already world-class and
 unique pharmaceutical services offering," said George Fotiades, president and
 chief executive officer of Life Sciences Products and Services to whom the
 Nuclear Pharmacy Services business will report.  "Through this acquisition,
 Cardinal Health offers health care providers the most comprehensive nuclear
 pharmacy services offering in the United States and our value to
 pharmaceutical manufacturers and biotechnology companies has been enhanced.
 In addition to compounding and distribution, we now provide the broadest range
 of commercialization and logistics solutions to the nuclear and complex
 pharmaceutical and biotech industries, helping important products reach the
 market faster and more efficiently."
     On January 1, 2003, Syncor became a wholly owned subsidiary of Cardinal
 Health.  Pursuant to the merger agreement dated June 14, 2002, as amended,
 each outstanding share of Syncor common stock has been converted into the
 right to receive 0.47 of a Cardinal Health common share, with cash being paid
 in lieu of fractional Cardinal Health common shares.  Share exchange
 instructions and a letter of transmittal will be mailed to Syncor shareholders
 shortly.  December 31, 2002 was the last day that Syncor common stock traded
 on The Nasdaq National Market.
     About Cardinal Health
     Cardinal Health, Inc. ( is the leading provider of
 products and services supporting the health care industry.  Cardinal Health
 companies develop, manufacture, package and market products for patient care;
 develop drug-delivery technologies; distribute pharmaceuticals, medical-
 surgical and laboratory supplies; and offer consulting and other services that
 improve quality and efficiency in health care.  Headquartered in Dublin, Ohio,
 Cardinal Health employs more than 49,000 people on five continents and
 produces annual revenues of more than $44 billion.  Cardinal Health is ranked
 #23 on the current Fortune 500 list and was named as one of "The World's Best"
 companies by Forbes magazine in 2002.
     Except for historical information, all other information in this news
 release consists of forward-looking statements within the meaning of the
 Private Securities Litigation Reform Act of 1995.  These forward-looking
 statements are subject to risks and uncertainties that could cause actual
 results to differ materially from those projected, anticipated or implied.
 The most significant of these uncertainties are described in Cardinal Health's
 Form 10-K, Form 8-K and Form 10-Q reports (including all amendments to those
 reports) and exhibits to those reports, and include (but are not limited to)
 the costs, difficulties, and uncertainties related to the integration of
 acquired businesses, the loss of one or more key customer or supplier
 relationships, changes in the distribution patterns or reimbursement rates for
 health-care products and/or services, the costs and other effects of
 governmental regulation and legal and administrative proceedings, and general
 economic and market conditions. Cardinal Health undertakes no obligation to
 update or revise any forward-looking statements.

SOURCE Cardinal Health, Inc